CytomX, Amgen pass on T cell engager; Molecular Partners ends work with Novartis

Plus, news about Atea Pharmaceuticals: CytomX, Amgen stop work on T cell engager: The partners decided to end development of an EGFR-targeting T cell engager based on “clinical observations to date ...